ZBIO
ZBIO
NASDAQ · Biotechnology

Zenas Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$19.64
+0.37 (+1.92%)
As of May 9, 9:39 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +50.3% upside
Low Target $22.12
Average Target $29.51
High Target $35.27
Current Price $19.64
Current
$19.64
Target
$29.51
$22.12 $29.51 avg $35.27
Scenario Analysis
Bear Case
$22.12
12.6%
Low target
Base Case
$29.51
+50.3%
Avg target
Bull Case
$35.27
+79.6%
High target
Risk/Reward
6.3x
Highly favorable
Price in Context
52-Week High
$44.60
-56.0% from high
52-Week Low
$8.51
+130.8% from low
Target vs 52W High
$29.51
-33.8% vs high
Next Earnings Report
May 14, 2026
3d
until earnings
EPS Est: $-1.62
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%